PRELUDE CAPITAL MANAGEMENT, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 193 filers reported holding CARDLYTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$243,000
-92.8%
1,916
-98.5%
0.01%
-95.8%
Q2 2019$3,361,000
+77.8%
129,377
+13.2%
0.16%
+55.7%
Q1 2019$1,890,000
+105.4%
114,254
+34.5%
0.11%
+71.0%
Q4 2018$920,00084,9200.06%
Other shareholders
CARDLYTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders